• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Professional Introduction to (1S,2S)-2-Benzyloxycyclopentylamine (CAS No. 181657-57-8)

(1S,2S)-2-Benzyloxycyclopentylamine is a highly specialized chiral amine derivative that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, identified by its CAS number 181657-57-8, represents a critical intermediate in the synthesis of various bioactive molecules. Its unique stereochemical configuration, characterized by a specific configuration at the 1S and 2S positions, makes it a valuable building block for the development of enantiomerically pure drugs and chiral catalysts.

The significance of chiral compounds in pharmaceuticals cannot be overstated. Chirality refers to the property of a molecule that makes it non-superimposable on its mirror image, much like a left hand cannot be perfectly aligned with a right hand. This property is crucial because many biological targets, such as enzymes and receptors, are also chiral and interact selectively with one enantiomer over another. Consequently, the use of enantiomerically pure compounds can lead to improved therapeutic efficacy and reduced side effects.

(1S,2S)-2-Benzyloxycyclopentylamine is particularly interesting due to its cyclopentyl backbone, which provides a rigid framework that can enhance binding affinity and selectivity in drug design. The benzyloxy group at the 2-position introduces additional functionality that can be modified through various chemical transformations, allowing for the synthesis of complex derivatives with tailored properties.

In recent years, there has been a surge in research focused on the development of novel chiral auxiliaries and ligands for asymmetric synthesis. These tools are essential for producing enantiomerically enriched compounds on an industrial scale. (1S,2S)-2-Benzyloxycyclopentylamine has emerged as a promising candidate in this context, serving as a versatile scaffold for generating new chiral entities.

The compound's utility extends beyond its role as an intermediate in drug synthesis. It has also been explored as a ligand in transition metal-catalyzed reactions, where its steric and electronic properties can influence reaction outcomes. For instance, palladium-catalyzed cross-coupling reactions involving this amine have shown promise in constructing complex organic molecules with high precision.

Advances in computational chemistry have further enhanced the understanding of how (1S,2S)-2-Benzyloxycyclopentylamine behaves in various chemical environments. Molecular modeling studies have revealed insights into its interactions with other molecules, providing valuable guidance for rational drug design. These computational approaches are increasingly being integrated into synthetic planning, enabling researchers to predict and optimize reaction pathways more efficiently.

The pharmaceutical industry has shown particular interest in developing treatments for neurological disorders, where chiral drugs often exhibit enhanced efficacy. (1S,2S)-2-Benzyloxycyclopentylamine has been investigated as a precursor for potential neuroactive compounds. Its structural features make it well-suited for designing molecules that interact with central nervous system receptors, offering hope for novel therapeutic strategies.

In addition to its pharmaceutical applications, this compound has found utility in materials science. Chiral amines like (1S,2S)-2-Benzyloxycyclopentylamine can be used to induce chirality in polymers and other materials, leading to advancements in areas such as liquid crystals and optoelectronics.

The synthesis of complex molecules often requires multi-step processes involving multiple stereocenters. (1S,2S)-2-Benzyloxycyclopentylamine provides a robust platform for constructing such molecules due to its well-defined stereochemistry and reactivity profile. Researchers have leveraged this compound to develop innovative synthetic routes that would be challenging to achieve using simpler starting materials.

The demand for high-quality intermediates like (1S,2S)-2-Benzyloxycyclopentylamine continues to grow as the pharmaceutical landscape evolves. Manufacturers specializing in fine chemicals have invested heavily in optimizing production processes to meet these demands while adhering to stringent quality control standards.

Eco-friendly chemistry is another area where this compound has made notable contributions. Green chemistry principles emphasize the development of synthetic methods that minimize waste and hazardous byproducts. The use of (1S,2S)-2-Benzyloxycyclopentylamine in catalytic reactions often aligns with these principles, contributing to more sustainable chemical practices.

The future prospects for (1S,2S)-2-Benzyloxycyclopentylamine are promising as research continues to uncover new applications and refine synthetic methodologies. Collaborative efforts between academia and industry are expected to drive innovation further, leading to groundbreaking discoveries in pharmaceuticals and beyond.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)